GeoVax Labs, Inc. (GOVX)
$0.27-3.57%Close
BUYCRISIS · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $258,787
- Beta
- 3.69
- P/E (TTM)
- -0.02
- Short % float
- 29.49%
- Days to cover
- 1.2
- SI change
- -43.5%
- 1W
- -6.90%
- 1M
- -37.21%
- vs SPY 1W
- -6.76%
- vs SPY 1M
- -39.72%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on GOVX?
- LOPJLB’s latest quantitative signal on GeoVax Labs, Inc. (GOVX) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is GOVX in?
- GeoVax Labs, Inc. (GOVX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does GeoVax Labs, Inc. (GOVX) do?
- GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing i…